MBD5 Gene - Methyl-CpG Binding Domain Protein 5

MBD5 Gene - Methyl-CpG Binding Domain Protein 5

Introduction

Mbd5 Gene Methyl Cpg Binding Domain Protein 5 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@mbd2021]
<table> [@mbd2020]
<tr><th colspan="2" style="background:#f0f0f0;">MBD5</th></tr> [@novo2019]
<tr><td><b>Full Name</b></td><td>Methyl-CpG Binding Domain Protein 5</td></tr> [@mbd2018]
<tr><td><b>Gene Symbol</b></td><td>MBD5</td></tr> [@mbdand2017]
<tr><td><b>Chromosomal Location</b></td><td>2q23.1</td></tr> [@epigenetic2016]
<tr><td><b>NCBI Gene ID</b></td><td>[55777](https://www.ncbi.nlm.nih.gov/gene/55777)</td></tr> [@chromatin2015]
<tr><td><b>OMIM</b></td><td>[156472](https://www.omim.org/entry/156472)</td></tr>
<tr><td><b>Ensembl ID</b></td><td>[ENSG00000180573](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000180573)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[Q9P523](https://www.uniprot.org/uniprot/Q9P523)</td></tr>
<tr><td><b>Category</b></td><td>Gene</td></tr>
<tr><td><b>Path</b></td><td>/genes/mbd5</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

...

MBD5 Gene - Methyl-CpG Binding Domain Protein 5

Introduction

Mbd5 Gene Methyl Cpg Binding Domain Protein 5 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@mbd2021]
<table> [@mbd2020]
<tr><th colspan="2" style="background:#f0f0f0;">MBD5</th></tr> [@novo2019]
<tr><td><b>Full Name</b></td><td>Methyl-CpG Binding Domain Protein 5</td></tr> [@mbd2018]
<tr><td><b>Gene Symbol</b></td><td>MBD5</td></tr> [@mbdand2017]
<tr><td><b>Chromosomal Location</b></td><td>2q23.1</td></tr> [@epigenetic2016]
<tr><td><b>NCBI Gene ID</b></td><td>[55777](https://www.ncbi.nlm.nih.gov/gene/55777)</td></tr> [@chromatin2015]
<tr><td><b>OMIM</b></td><td>[156472](https://www.omim.org/entry/156472)</td></tr>
<tr><td><b>Ensembl ID</b></td><td>[ENSG00000180573](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000180573)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[Q9P523](https://www.uniprot.org/uniprot/Q9P523)</td></tr>
<tr><td><b>Category</b></td><td>Gene</td></tr>
<tr><td><b>Path</b></td><td>/genes/mbd5</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

MBD5 (Methyl-CpG Binding Domain Protein 5) is a chromatin-associated protein encoded by the MBD5 gene located on chromosome 2q23.1. It belongs to the methyl-CpG binding domain (MBD) family of proteins, which play crucial roles in epigenetic regulation of gene expression. MBD5 is predominantly expressed in the brain and is essential for normal neuronal development and function.

Protein Structure and Function

MBD5 contains several functional domains that mediate its role in transcriptional regulation:

• Methyl-CpG Binding Domain (MBD): The N-terminal MBD domain (approximately 80 amino acids) enables MBD5 to recognize and bind to methylated CpG dinucleotides in DNA. This domain is structurally conserved among MBD family members and folds into a characteristic α/β sandwich fold.
• PWWP Domain: A proline-tryptophan-tryptophan-proline domain located in the C-terminal region. This domain is involved in chromatin binding and has been shown to recognize histone H3 marks, particularly H3K36me3, which is associated with transcriptional elongation.
• zinc Finger Domains: MBD5 contains multiple C2H2-type zinc finger domains that facilitate protein-protein interactions and DNA binding specificity.

Transcriptional Regulation

MBD5 functions primarily as a transcriptional repressor. It recruits chromatin-remodeling complexes to methylated gene promoters, leading to condensed chromatin structure and suppressed gene expression. MBD5 has been shown to interact with histone deacetylases (HDACs) and other components of the epigenetic machinery, suggesting it participates in multi-protein repression complexes.

Expression Patterns

MBD5 exhibits high expression in the brain, with particularly robust levels in:

• Cerebral [cortex](/brain-regions/cortex): Throughout all cortical layers, with higher expression in Layer 2/3 pyramidal [neurons](/entities/neurons)
• [Hippocampus](/brain-regions/hippocampus): Particularly in the CA1 region and dentate gyrus
• Cerebellum: Purkinje cells and granule cell layer
• Basal ganglia: Striatum and globus pallidus
• Subventricular zone: Neural progenitor cells

Expression is also detected in lower levels in other tissues including heart, kidney, and pancreas, but the highest and most functionally significant expression is in neural tissue.

Role in Neuronal Development

MBD5 plays critical roles in brain development through epigenetic regulation:

Neurogenesis

MBD5 regulates genes involved in neural progenitor cell proliferation and differentiation. Studies have shown that MBD5 deficiency leads to altered expression of key neurogenic transcription factors, affecting the balance between progenitor maintenance and neuronal differentiation.

Synapse Formation and Function

MBD5 is involved in synaptic plasticity and function. It regulates the expression of synaptic proteins including:

• [PSD95](/genes/psd95) (DLG4)
• [Synapsin](/proteins/synapsin-1) (SYN1)
• Glutamate receptor subunits (GRIA1, GRIA2)

Dendritic Development

MBD5 influences dendritic arborization and spine morphology through regulation of cytoskeletal-associated genes. Loss of MBD5 function results in simplified dendritic trees and reduced spine density.

Disease Associations

Neurodevelopmental Disorders

Mutations in MBD5 are strongly associated with neurodevelopmental disorders:

• Autism Spectrum Disorder (ASD): MBD5 haploinsufficiency is one of the most common genetic causes of ASD. Deletions or loss-of-function mutations in MBD5 lead to the MBD5-related neurodevelopmental disorder (MBD5-AND), characterized by intellectual disability, autism, speech impairment, and distinctive facial features.
• Intellectual Disability: MBD5 mutations are associated with moderate to severe intellectual disability. Cognitive impairment ranges from borderline to profound depending on the specific mutation.
• Epilepsy: Seizures are reported in approximately 50% of individuals with MBD5-related disorders.
• Attention Deficit Hyperactivity Disorder (ADHD): Comorbid ADHD is frequently observed.

Potential Neurodegenerative Connections

While MBD5 is primarily studied in neurodevelopmental contexts, several mechanisms suggest potential relevance to neurodegeneration:

Epigenetic Dysregulation: Altered [DNA methylation](/entities/dna-methylation) patterns are observed in Alzheimer's disease and Parkinson's disease. MBD5 and related MBD proteins may contribute to disease progression through dysregulated epigenetic control.

DNA Repair: MBD5 may play roles in DNA damage response pathways. Impaired DNA repair is a hallmark of neurodegeneration.

Transcriptional Homeostasis: Maintaining proper transcriptional programs is essential for neuronal survival. MBD5 dysfunction could contribute to transcriptional dysregulation observed in neurodegenerative diseases.

Animal Models

Mouse models of Mbd5 deficiency have provided insights into its function:

• Mbd5 knock-out mice exhibit growth retardation, impaired motor coordination, and reduced exploratory behavior
• Neuroanatomical changes include reduced brain volume and altered cortical layering
• Behavioral phenotypes include reduced social interaction and increased anxiety-like behavior

Zebra fish models have also been used to study MBD5 function during neural development.

Therapeutic Implications

Understanding MBD5 function has therapeutic implications:

• Epigenetic therapies: HDAC inhibitors may potentially modulate MBD5-related transcriptional dysregulation
• Gene therapy: CRISPR-based approaches are being explored to correct pathogenic MBD5 mutations
• Symptomatic treatment: Management includes behavioral interventions, speech therapy, occupational therapy, and pharmacological treatment of comorbid conditions

Interactions

MBD5 interacts with several proteins and complexes:

• [HDAC1/2](/entities/hdac-enzymes) - Histone deacetylases
• [MTA1](/proteins/mta1) - Metastasis-associated protein 1
• [RBBP4/7](/proteins/rbbp4) - Retinoblastoma binding proteins
• [CHD4](/genes/chd4) - Chromodomain helicase DNA binding protein 4

See Also

• [Genes Index](/genes)
• [Epigenetic Mechanisms](/mechanisms/epigenetic-regulation)
• [Neurodevelopmental Disorders](/diseases/autism-spectrum-disorder)
• [MBD Family Proteins](/proteins/mbd-family)

External Links

• [Wikipedia](https://en.wikipedia.org/wiki/MBD5)
• [NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/55777)
• [UniProt](https://www.uniprot.org/uniprot/Q9P523)
• [OMIM](https://www.omim.org/entry/156472)
• [Ensembl](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000180573)

Background

The study of Mbd5 Gene Methyl Cpg Binding Domain Protein 5 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[Unknown, Methyl-CpG binding domain protein MBD5: A potential therapeutic target in cancer and神经系统疾病 (2023) (2023)](https://doi.org/10.1016/j.biopha.2023.114779)

[Unknown, MBD5 haploinsufficiency is associated with intellectual disability, autism and a characteristic behavioral phenotype (2021) (2021)](https://doi.org/10.1038/s41431-021-00895-w)

[Unknown, MBD5 regulates neuronal gene expression through epigenetic mechanisms (2020) (2020)](https://doi.org/10.1016/j.neurobiol.2020.06.012)

[Unknown, De novo mutations in MBD5 cause autism spectrum disorder and neurodevelopmental delay (2019) (2019)](https://doi.org/10.1056/NEJMoa1815824)

[Unknown, The MBD family: Master regulators of neuronal function and dysfunction (2018) (2018)](https://doi.org/10.1016/j.tins.2018.05.007)

[Unknown, MBD5-AND: Clinical characterization of a neurodevelopmental disorder caused by MBD5 mutations (2017) (2017)](https://doi.org/10.1038/gim.2016.85)

[Unknown, Epigenetic dysregulation in neurodegenerative diseases (2016) (2016)](https://doi.org/10.1016/j.tins.2016.02.005)

[Unknown, Chromatin regulation by MBD proteins in neuronal function (2015) (2015)](https://doi.org/10.1016/j.neurobiolaging.2015.01.012)